Articles Tagged With: guidance
-
CDC Guidelines for Home Isolation for Coronavirus
The Centers for Disease Control and Prevention has issued new guidelines for home care and isolation of patients with emerging 2019-nCoV.
-
IHI Provides Practical Steps for Reducing Morbidity and Mortality From Opioids
Simply reducing the number of opioid prescriptions is not enough, the report authors wrote. Hospitals must be much more proactive in identifying patients with opioid use disorder and initiating treatment wherever those patients are encountered within the treatment process.
-
Updated Guidance Issued to Aid in Care of Sexual Assault Survivors
The American College of Obstetricians and Gynecologists has issued updated guidance to aid clinicians with screening protocols and providing resources in caring for sexual assault survivors.
-
The Well-Woman Visit: Understand New Guidance
A new committee opinion issued by the American College of Obstetricians and Gynecologists, in conjunction with the Women’s Preventive Services Initiative’s rollout of a “Well-Woman Chart,” is designed to help clinicians follow the latest updates for preventive care.
-
USPSTF Issues Final Guidance for Cervical Cancer Screening
The US Preventive Services Task Force has issued final recommendations for cervical cancer screening, calling for women ages 21 to 29 to be tested with cervical cytology every three years.
-
Task Force Recommends Against Hormone Therapy for Chronic Conditions
The U.S. Preventive Services Task Force has issued a final recommendation statement and evidence summary upholding its earlier recommendation against use of hormone therapy for the primary prevention of chronic conditions in postmenopausal women.
-
U.S. MEC Updates Contraceptive Information for Women With HIV
The Centers for Disease Control and Prevention is revising its recommendation on the use of the progestin-only contraception injection depot medroxyprogesterone acetate (DMPA) by women at high risk for HIV from Category 1 (no restriction) to Category 2 (benefits outweigh theoretical or proven risks).
-
Task Force Issues Cervical Cancer Screening Guidance: What Changes Can Clinicians Expect?
Ages 30-65: Cervical cytology every three years or HPV testing every five years.
-
Task Force Issues Draft Guidance on Ovarian Screening
The U.S. Preventive Services Task Force has issued a draft recommendation statement on ovarian screening, finding that the potential harms of screening outweigh the benefits.
-
OHRP’s standard of care draft guidance elicits praise, criticism
Critics and supporters both have weighed in on recent standard of care guidance published by the Office for Human Research Protections (OHRP).